By otakuyassine3@gmail.com 
Phreesia, Inc. (NYSE:PHR – Get Free Report) General Counsel Allison C. Hoffman sold 6,556 shares of the business’s stock in a transaction that occurred on Monday, January 27th. The shares were sold at an average price of $27.48, for a total value of $180,158.88. Following the completion of the sale, the general counsel now owns 152,361 shares in the company, valued at $4,186,880.28. The trade was a 4.13 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link.
Phreesia Stock Performance
NYSE PHR traded down $0.49 during trading hours on Wednesday, reaching $28.81. 384,950 shares of the company were exchanged, compared to its average volume of 392,842. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04. The stock has a market capitalization of $1.67 billion, a P/E ratio of -19.60 and a beta of 0.94. The business’s 50 day simple moving average is $24.57 and its 200-day simple moving average is $23.20. Phreesia, Inc. has a 1 year low of $17.07 and a 1 year high of $29.90.
Phreesia (NYSE:PHR – Get Free Report) last posted its quarterly earnings results on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, topping the consensus estimate of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The company had revenue of $106.80 million during the quarter, compared to the consensus estimate of $106.33 million. During the same quarter in the prior year, the company earned ($0.58) EPS. The firm’s quarterly revenue was up 16.6% compared to the same quarter last year. On average, equities research analysts expect that Phreesia, Inc. will post -1.1 earnings per share for the current year.
Analysts Set New Price Targets
A number of analysts recently issued reports on the company. Truist Financial upped their target price on Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. JMP Securities restated a “market outperform” rating and set a $30.00 price objective on shares of Phreesia in a research report on Tuesday, December 10th. Piper Sandler reissued an “overweight” rating and set a $33.00 price target (up from $31.00) on shares of Phreesia in a report on Wednesday. Royal Bank of Canada raised Phreesia from a “sector perform” rating to an “outperform” rating and upped their price objective for the company from $24.00 to $32.00 in a report on Wednesday, January 8th. Finally, KeyCorp lifted their price objective on shares of Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 8th. Thirteen analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus target price of $31.15.
Read Our Latest Analysis on Phreesia
Hedge Funds Weigh In On Phreesia
Several large investors have recently modified their holdings of PHR. Trust Point Inc. boosted its stake in Phreesia by 3.5% during the third quarter. Trust Point Inc. now owns 17,887 shares of the company’s stock valued at $408,000 after buying an additional 607 shares during the period. The Manufacturers Life Insurance Company raised its holdings in shares of Phreesia by 3.3% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 27,935 shares of the company’s stock valued at $637,000 after acquiring an additional 905 shares in the last quarter. MetLife Investment Management LLC boosted its position in shares of Phreesia by 3.8% during the 3rd quarter. MetLife Investment Management LLC now owns 30,781 shares of the company’s stock valued at $701,000 after acquiring an additional 1,120 shares during the last quarter. R Squared Ltd purchased a new position in shares of Phreesia during the fourth quarter worth about $30,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Phreesia by 9.9% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 14,015 shares of the company’s stock worth $319,000 after purchasing an additional 1,258 shares during the last quarter. Hedge funds and other institutional investors own 92.10% of the company’s stock.
About Phreesia
Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.
Featured Stories
Receive News & Ratings for Phreesia Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Phreesia and related companies with MarketBeat.com’s FREE daily email newsletter.